Unbelievable folly of clinical trials in heart failure

Circulation: Heart Failure

Volumn 9, Issue 4, 2016, Pages

  Packer, Milton ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

clinical trials; heart failure

Indexed keywords

BIOASSAY; CLINICAL TRIAL (TOPIC); EVIDENCE BASED MEDICINE; HEART FAILURE; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROCEDURES; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; EVIDENCE-BASED MEDICINE; HEART FAILURE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RESEARCH DESIGN; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84964417462     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.116.002837     Document Type: Note

References (35)

1. Szabó C, Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007 6 917 935. doi: 10.1038/nrd2425.
2. Calvert JW, Elston M, Nicholson CK, Gundewar S, Jha S, Elrod JW, Ramachandran A, Lefer DJ, Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice. Circulation 2010 122 11 19. doi: 10.1161/CIRCULATIONAHA.109.920991.
3. Nicholson CK, Lambert JP, Molkentin JD, Sadoshima J, Calvert JW, Thioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failure. Arterioscler Thromb Vasc Biol 2013 33 744 751. doi: 10.1161/ATVBAHA.112.300484.
4. Polhemus DJ, Kondo K, Bhushan S, Bir SC, Kevil CG, Murohara T, Lefer DJ, Calvert JW, Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis. Circ Heart Fail 2013 6 1077 1086. doi: 10.1161/CIRCHEARTFAILURE.113.000299.
5. Mishra PK, Tyagi N, Sen U, Givvimani S, Tyagi SC, H2S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure. Am J Physiol Heart Circ Physiol 2010 298 H451 H456. doi: 10.1152/ajpheart.00682.2009.
6. Barr LA, Shimizu Y, Lambert JP, Nicholson CK, Calvert JW, Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress. Nitric Oxide 2015 46 145 156. doi: 10.1016/j.niox.2014.12.013.
7. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ, Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 2009 105 365 374. doi: 10.1161/CIRCRESAHA.109.199919.
8. Wang X, Robbins J, Heart failure and protein quality control. Circ Res 2006 99 1315 1328. doi: 10.1161/01.RES.0000252342.61447.a2.
9. Wang X, Robbins J, Proteasomal and lysosomal protein degradation and heart disease. J Mol Cell Cardiol 2014 71 16 24. doi: 10.1016/j.yjmcc.2013.11.006.
10. Li YF, Wang X, The role of the proteasome in heart disease. Biochim Biophys Acta 2011 1809 141 149. doi: 10.1016/j.bbagrm.2010.09.001.
11. Ferreira JC, Boer BN, Grinberg M, Brum PC, Mochly-Rosen D, Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3. PLoS One 2012 7 e33175. doi: 10.1371/journal.pone.0033175.
12. Patterson C, Ike C, Willis PW IV, Stouffer GA, Willis MS, The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Circulation 2007 115 1456 1463. doi: 10.1161/CIRCULATIONAHA.106.649863.
13. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI, Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 2001 276 30057 30063. doi: 10.1074/jbc.M100142200.
14. Li J, Horak KM, Su H, Sanbe A, Robbins J, Wang X, Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J Clin Invest 2011 121 3689 3700. doi: 10.1172/JCI45709.
15. Glickman MH, Ciechanover A, The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002 82 373 428. doi: 10.1152/physrev.00027.2001.
16. Kwak MK, Wakabayashi N, Itoh K, Motohashi H, Yamamoto M, Kensler TW, Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J Biol Chem 2003 278 8135 8145. doi: 10.1074/jbc.M211898200.
17. Pickering AM, Linder RA, Zhang H, Forman HJ, Davies KJ, Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress. J Biol Chem 2012 287 10021 10031. doi: 10.1074/jbc.M111.277145.
18. Kapeta S, Chondrogianni N, Gonos ES, Nuclear erythroid factor 2-mediated proteasome activation delays senescence in human fibroblasts. J Biol Chem 2010 285 8171 8184. doi: 10.1074/jbc.M109.031575.
19. Kathiria AS, Butcher MA, Hansen JM, Theiss AL, Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis. Am J Physiol Gastrointest Liver Physiol 2013 304 G885 G896. doi: 10.1152/ajpgi.00327.2012.
20. Drews O, Tsukamoto O, Liem D, Streicher J, Wang Y, Ping P, Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy. Circ Res 2010 107 1094 1101. doi: 10.1161/CIRCRESAHA.110.222364.
21. Koike S, Ogasawara Y, Shibuya N, Kimura H, Ishii K, Polysulfide exerts a protective effect against cytotoxicity caused by t-buthylhydroperoxide through Nrf2 signaling in neuroblastoma cells. FEBS Lett 2013 587 3548 3555. doi: 10.1016/j.febslet.2013.09.013.
22. Peake BF, Nicholson CK, Lambert JP, Hood RL, Amin H, Amin S, Calvert JW, Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner. Am J Physiol Heart Circ Physiol 2013 304 H1215 H1224. doi: 10.1152/ajpheart.00796.2012.
23. Xu J, Zhou Q, Xu W, Cai L, Endoplasmic reticulum stress and diabetic cardiomyopathy. Exp Diabetes Res 2012 2012 827971. doi: 10.1155/2012/827971.
24. Predmore JM, Wang P, Davis F, Bartolone S, Westfall MV, Dyke DB, Pagani F, Powell SR, Day SM, Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation 2010 121 997 1004. doi: 10.1161/CIRCULATIONAHA.109.904557.
25. Chen Q, Liu JB, Horak KM, Zheng H, Kumarapeli AR, Li J, Li F, Gerdes AM, Wawrousek EF, Wang X, Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ Res 2005 97 1018 1026. doi: 10.1161/01.RES.0000189262.92896.0b.
26. Sanbe A, Osinska H, Saffitz JE, Glabe CG, Kayed R, Maloyan A, Robbins J, Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A 2004 101 10132 10136. doi: 10.1073/pnas.0401900101.
27. Herrmann J, Wohlert C, Saguner AM, Flores A, Nesbitt LL, Chade A, Lerman LO, Lerman A, Primary proteasome inhibition results in cardiac dysfunction. Eur J Heart Fail 2013 15 614 623. doi: 10.1093/eurjhf/hft034.
28. Zhou S, Sun W, Zhang Z, Zheng Y, The role of Nrf2-mediated pathway in cardiac remodeling and heart failure. Oxid Med Cell Longev 2014 2014 260429. doi: 10.1155/2014/260429.
29. Wang W, Li S, Wang H, Li B, Shao L, Lai Y, Horvath G, Wang Q, Yamamoto M, Janicki JS, Wang XL, Tang D, Cui T, Nrf2 enhances myocardial clearance of toxic ubiquitinated proteins. J Mol Cell Cardiol 2014 72 305 315. doi: 10.1016/j.yjmcc.2014.04.006.
30. Li J, Ichikawa T, Villacorta L, Janicki JS, Brower GL, Yamamoto M, Cui T, Nrf2 protects against maladaptive cardiac responses to hemodynamic stress. Arterioscler Thromb Vasc Biol 2009 29 1843 1850. doi: 10.1161/ATVBAHA.109.189480.
31. Lastres-Becker I, Ulusoy A, Innamorato NG, Sahin G, Rábano A, Kirik D, Cuadrado A, Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease. Hum Mol Genet 2012 21 3173 3192. doi: 10.1093/hmg/dds143.
32. Kensler TW, Wakabayashi N, Biswal S, Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007 47 89 116. doi: 10.1146/annurev.pharmtox.46.120604.141046.
33. Bloom DA, Jaiswal AK, Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression. J Biol Chem 2003 278 44675 44682. doi: 10.1074/jbc.M307633200.
34. Sun Z, Huang Z, Zhang DD, Phosphorylation of Nrf2 at multiple sites by MAP kinases has a limited contribution in modulating the Nrf2-dependent antioxidant response. PLoS One 2009 4 e6588. doi: 10.1371/journal.pone.0006588.
35. Xie H, Xu Q, Jia J, Ao G, Sun Y, Hu L, Alkayed NJ, Wang C, Cheng J, Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-Activated protein kinase to restore autophagic flux. Biochem Biophys Res Commun 2015 458 632 638. doi: 10.1016/j.bbrc.2015.02.017.